Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BGM Group Ltd. (BGM) vs Organigram Global Inc. (OGI)

BGM Group Ltd. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Organigram Global Inc. is the larger, with a market value of $155.1M against $104.6M — 1.5× the size. Organigram Global Inc. trades at the lower P/E: 2.4× against 4.0×. Organigram Global Inc. has the higher net margin (28.4% vs 1.96%) and the lower return on invested capital (−1.53% vs 0.00%). Across the 16 metrics below, Organigram Global Inc. leads on 10 and BGM Group Ltd. on 6.

Valuation

Metric BGM OGI Drug Manufacturers Specialty & Generic median
P/E 4.00 2.37 20.14
P/S n/m 0.67 2.25
P/B n/m 0.42 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 16.79 12.29
EV/Sales (0.09) 0.70 2.56
Earnings yield 25.00% 42.26% (2.99%)
Free cash flow yield 0.00% (14.22%) 0.00%

Profitability

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 36.47% 53.94%
Operating margin 0.00% (3.91%) 0.00%
Net margin 1.96% 28.44% 0.00%
Free cash flow margin 0.00% (9.46%) 0.00%
Return on equity 0.00% 20.20% (0.40%)
Return on assets 0.00% 12.70% (3.32%)
Return on invested capital 0.00% (1.53%) 0.00%

Growth

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 39.51% 10.01%
EPS growth (last fiscal year) 10.00% 60.00% —
Revenue growth, 5-year CAGR (5.39%) 24.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.04 0.05
Current ratio 1.25 2.61 2.31
Net debt to EBITDA 0.97 (31.56) 0.85

Dividend

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Market cap 104.61m 155.11m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack